Symptoms in advanced pancreatic cancer are of importance for energy intake
- 750 Downloads
Cancer cachexia and low energy intake (EI) probably contribute to weight loss in advanced pancreatic cancer (PC). However, little is known about the actual EI in this disease. Aims were to assess EI, weight loss and symptoms during the disease course and investigate associations between symptoms and EI.
Thirty-nine patients (21 males) with advanced PC were consecutively included and followed every 4 weeks until the end of life. A 24-h dietary recall was used to assess EI. The Edmonton Symptom Assessment System (ESAS) and the PC-specific health-related quality of life questionnaire (QLQ-PAN26) were used for symptom assessment.
Median age was 62 years (48–88), WHO performance status 1 (0–2) and survival 5 months (1–25). Seventeen (44 %) patients had unresectable cancer, 16 (41 %) metastatic and six (15 %) recurrent disease. Upon inclusion, 37 (95 %) reported weight loss (median 4.0 kg per month). During follow-up, median weight loss per month was <1.0 kg. Forty to 65 % had EI <29 kcal/kg/day (cut-off value for weight maintenance) during the observation period but they did not lose more weight than patients with EI ≥ 29 kcal. Strong negative correlations (r range) were found between EI and pain (0.51–0.61), fatigue (0.54–0.67), oral dryness (0.61–0.64) and loss of appetite (0.53–0.71).
In this study, several symptoms influenced EI negatively. Low EI did not completely explain weight loss in this patient group, but careful monitoring and early follow-up of symptoms may be important interventions to reduce weight loss in advanced PC.
KeywordsPancreatic cancer Weight loss Symptoms Food intake
The authors wish to thank the clinical staff at the Department of Oncology and the Palliative Medicine Unit at Oslo University Hospital for their cooperation. We also want to thank Jurate Saltyte-Benth, Institute of Clinical Medicine, University of Oslo for all statistical assistance.
Conflict of Interest
The authors report no conflicts of interest. The authors alone have full control of all primary data and agree to allow the journal to review the data if requested.
- 2.Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799. doi: S0261-5614(08)00113-1 [pii]10.1016/j.clnu.2008.06.013 PubMedCrossRefGoogle Scholar
- 3.Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495Google Scholar
- 4.Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46. doi: 10.1007/s00520-006-0091-0 PubMedCrossRefGoogle Scholar
- 7.Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.1016/j.critrevonc.2010.10.004
- 8.Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531–1541. doi: 10.1007/s00520-009-0623-5 PubMedCrossRefGoogle Scholar
- 12.Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189–2198PubMedCrossRefGoogle Scholar
- 13.Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24(21):3401–3407. doi: 24/21/3401 [pii] 10.1200/JCO.2005.04.5724 PubMedCrossRefGoogle Scholar
- 15.Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi: 10.1007/s00520-010-1011-x
- 16.Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo]Google Scholar
- 18.Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, OsloGoogle Scholar
- 19.Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7Google Scholar
- 20.National food database, version 24/03/2010 (2010) http://www7.slv.se/livsmedelssok/
- 22.Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRefGoogle Scholar
- 23.Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939–941PubMedCrossRefGoogle Scholar
- 27.Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, BelgiumGoogle Scholar
- 28.Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, HillsdaleGoogle Scholar
- 30.Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New YorkGoogle Scholar
- 33.Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi: 10.1007/978-1-84882-118-7_8
- 39.Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manag 32(4):322–331. doi: S0885-3924(06)00458-1 [pii] 10.1016/j.jpainsymman.2006.05.012 CrossRefGoogle Scholar
- 43.Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165. doi: S0885-3924(06)00630-0 [pii]10.1016/j.jpainsymman.2006.07.017 CrossRefGoogle Scholar